论文部分内容阅读
目的:调查分析人血白蛋白用药现状,探讨该制剂临床使用的合理性。方法:回顾性调查某三甲综合医院2014年4~6月所有使用人血白蛋白的住院患者病历,分析其用药合理性。结果:该院3个月内共有180例患者使用人血白蛋白,使用覆盖的临床科室广泛,几乎涉及全身各个系统疾病,总用量为9 345支,总金额约为34.8万元,占患者住院总费用近8%,总药品费用近11%。指南适应证符合率约为21.1%。结论:该院人血白蛋白临床应用不甚规范,需进一步加强管理,节约医疗资源,降低患者负担,同时呼吁尽快制定基于循证医学依据的指南作为指导,规范白蛋白临床应用。
Objective: To investigate and analyze the present situation of human serum albumin and to explore the rationality of its clinical use. Methods: The medical records of all inpatients using human serum albumin from April to June 2014 in a Grade A general hospital were retrospectively investigated, and their rationality of medication was analyzed. Results: A total of 180 patients were treated with human serum albumin within 3 months. The clinical departments covered a wide range of subjects and covered almost all systemic diseases with a total amount of 9 345. The total amount was about 348 thousand yuan, accounting for the hospitalization Nearly 8% of the total cost, nearly 11% of the total drug costs. The compliance rate of the guideline is about 21.1%. Conclusion: The clinical application of albumin in this hospital is not standardized, so it is necessary to further strengthen management, save medical resources and reduce the burden on patients. At the same time, it is urged to develop a guideline based on evidence - based medicine as soon as possible to standardize the clinical application of albumin.